Scientists from Friedrich-Alexander-University Erlangen-Nuremberg and Ruhr University Bochum in Germany conducted a research which showed that intestinal flora, as well as the type of fatty acids in the daily diet, through the influence on the cells of the immune system have an impact on exacerbation of multiple sclerosis. The results of the study were published in “Immunity” magazine. Read full text »
For many years it was thought that women suffering from multiple sclerosis should not decide to become mothers because of the risk of worsening of their condition. Postnatal period was regarded as one of the risk factors of new relapses. German researchers conducted a study and its aim was to compare the disease in the postnatal period in women who exclusively breastfed, with those who breastfed partially or not fed at all. The latest results published in the journal JAMA Neurology by a group of researchers at the Ruhr-University Bochum in Germany demonstrate that breastfeeding may prevent the development of the disease in women after childbirth.
Results of studies which suggest that drinking coffee may reduce the risk of multiple sclerosis (MS) development were presented during the 67th annual symposium of the American Academy of Neurology in Washington. Read full text »
Multiple sclerosis (Multiple sclerosis – MS) is a chronic, inflammatory autoimmune disorder of the central nervous system. The prevalence of MS varies from 2 to 150 patients per 100 000 inhabitants, depending on geographic region. The first symptoms usually appear between 20 and 40 years of age. It occurs twice as often in women than in men. Potential causes of multiple sclerosis include genetic, environmental or infectious factors. New study published in the Journal of Neurology, Neurosurgery & Psychiatry suggested a potential link between Helicobacter pylori infection and the prevalence of multiple sclerosis.
A team of scientists from Canada has identified a mechanism responsible for neurodegeneration in amyotrophic lateral sclerosis (ALS). They suggest that owing to their discovery it will be possible to introduce targeted therapy aimed at inhibition of the disease’s development. The research were published in Proceedings of the National Academy of Sciences magazine. Read full text »
Sclerosis multiplex is the most common inflammatory demyelinating disease of the central nervous system. Scientists have been looking for its reasons for years since it would allow to devise specific medication. Among supposed etiological reasons are genetic burdens, autoimmune reactions and environmental factors. Read full text »
Researchers from Sapienza University of Rome announce that vaccine against tuberculosis (Bacillus Calmette-Guerin – BCG) administered after the first symptoms of sclerosis multiplex may inhibit progression of the disease.
Multiple sclerosis (MS) is a chronic inflammatory disease that involves a destruction of central nervous system’s axons. The destructive process affects neurons, oligodendrocytes and microglia. The disease leads to a progressive disability. Researchers at Northwestern University in the U.S. have created biodegradable nanoparicles that may provide a mean of transport for antigens. The antigens proved to have an ability to halt the immune system from destroying myelin sheaths of the neurons. Studies performed on laboratory rodents have shown the effectiveness of the method in the fight against remitting-relapsing multiple sclerosis. Read full text »
Multiple sclerosis is the most common neurological disease, affecting chiefly young people. It leads to damage of the central nervous system due to abnormal activity of autoreactive T cells, which results in damage of myelin sheath of neurons and formation of so-called demyelinating plaques. As a consequence, we can observe a broad spectrum of symptoms, including optic neuritis, pyramidal weakness, sensory disturbances, cerebellar ataxia, dizziness or spastic bladder. Clinically, MS may occur as a relapsing-remitting or chronic. Unfortunately, each type eventually leads to the irreversible progression of the CNS and progression of neurological symptoms. Read full text »